|
Yunnan Baiyao Group Co., Ltd (000538.sz) Avaliação DCF
CN | Healthcare | Drug Manufacturers - Specialty & Generic | SHZ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Yunnan Baiyao Group Co.,Ltd (000538.SZ) Bundle
Simplifique o Yunnan Baiyao Group Co., Ltd Avaliação com esta calculadora DCF personalizável! Com o Real Yunnan Baiyao Group Co., Ltd Financials e insumos de previsão ajustável, você pode testar cenários e descobrir o Yunnan Baiyao Group Co., Ltd Fair Value em minutos.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 29,664.7 | 32,742.8 | 36,373.9 | 36,488.4 | 39,111.3 | 41,943.9 | 44,981.6 | 48,239.3 | 51,732.9 | 55,479.6 |
| Revenue Growth, % | 0 | 10.38 | 11.09 | 0.31466 | 7.19 | 7.24 | 7.24 | 7.24 | 7.24 | 7.24 |
| EBITDA | 5,087.5 | 7,162.4 | 3,926.0 | 3,898.5 | 4,621.3 | 6,066.6 | 6,506.0 | 6,977.1 | 7,482.4 | 8,024.3 |
| EBITDA, % | 17.15 | 21.87 | 10.79 | 10.68 | 11.82 | 14.46 | 14.46 | 14.46 | 14.46 | 14.46 |
| Depreciation | 177.5 | 189.4 | 365.7 | 480.9 | 373.2 | 373.7 | 400.7 | 429.7 | 460.9 | 494.2 |
| Depreciation, % | 0.59827 | 0.5784 | 1.01 | 1.32 | 0.95419 | 0.89085 | 0.89085 | 0.89085 | 0.89085 | 0.89085 |
| EBIT | 4,910.0 | 6,973.0 | 3,560.3 | 3,417.5 | 4,248.1 | 5,692.9 | 6,105.2 | 6,547.4 | 7,021.6 | 7,530.1 |
| EBIT, % | 16.55 | 21.3 | 9.79 | 9.37 | 10.86 | 13.57 | 13.57 | 13.57 | 13.57 | 13.57 |
| Total Cash | 21,815.4 | 26,508.5 | 23,591.0 | 15,471.8 | 17,029.5 | 25,610.9 | 27,465.7 | 29,454.9 | 31,588.1 | 33,875.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 5,602.2 | 8,327.5 | 8,670.7 | 10,714.0 | 11,784.5 | 10,708.2 | 11,483.7 | 12,315.4 | 13,207.3 | 14,163.8 |
| Account Receivables, % | 18.89 | 25.43 | 23.84 | 29.36 | 30.13 | 25.53 | 25.53 | 25.53 | 25.53 | 25.53 |
| Inventories | 11,746.9 | 10,990.3 | 8,379.2 | 7,993.2 | 6,442.2 | 11,289.5 | 12,107.1 | 12,983.9 | 13,924.3 | 14,932.7 |
| Inventories, % | 39.6 | 33.57 | 23.04 | 21.91 | 16.47 | 26.92 | 26.92 | 26.92 | 26.92 | 26.92 |
| Accounts Payable | 6,243.9 | 6,315.6 | 6,437.6 | 6,631.2 | 6,210.5 | 7,725.0 | 8,284.5 | 8,884.5 | 9,527.9 | 10,218.0 |
| Accounts Payable, % | 21.05 | 19.29 | 17.7 | 18.17 | 15.88 | 18.42 | 18.42 | 18.42 | 18.42 | 18.42 |
| Capital Expenditure | -783.3 | -486.4 | -534.2 | -446.7 | -575.5 | -695.5 | -745.8 | -799.9 | -857.8 | -919.9 |
| Capital Expenditure, % | -2.64 | -1.49 | -1.47 | -1.22 | -1.47 | -1.66 | -1.66 | -1.66 | -1.66 | -1.66 |
| Tax Rate, % | 15.03 | 15.03 | 15.03 | 15.03 | 15.03 | 15.03 | 15.03 | 15.03 | 15.03 | 15.03 |
| EBITAT | 4,346.5 | 5,655.5 | 2,868.3 | 3,037.1 | 3,609.5 | 4,827.9 | 5,177.6 | 5,552.6 | 5,954.7 | 6,386.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -7,364.5 | 3,461.4 | 5,089.7 | 1,607.7 | 3,467.0 | 2,249.6 | 3,798.8 | 4,073.9 | 4,369.0 | 4,685.4 |
| WACC, % | 6.31 | 6.3 | 6.3 | 6.31 | 6.3 | 6.3 | 6.3 | 6.3 | 6.3 | 6.3 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 15,742.2 | |||||||||
| Long Term Growth Rate, % | 3.00 | |||||||||
| Free cash flow (T + 1) | 4,826 | |||||||||
| Terminal Value | 146,111 | |||||||||
| Present Terminal Value | 107,636 | |||||||||
| Enterprise Value | 123,378 | |||||||||
| Net Debt | -12,297 | |||||||||
| Equity Value | 135,675 | |||||||||
| Diluted Shares Outstanding, MM | 1,788 | |||||||||
| Equity Value Per Share | 75.89 |
What You Will Receive
- Comprehensive Yunnan Baiyao Data: Preloaded financial metrics – ranging from revenue to EBIT – based on actual and projected figures.
- Complete Customization: Modify all essential parameters (yellow cells) such as WACC, growth rates, and tax percentages.
- Instant Valuation Updates: Automatic recalculations to evaluate the effects of changes on Yunnan Baiyao Group's fair value.
- Flexible Excel Template: Designed for quick adjustments, scenario analyses, and in-depth projections.
- Efficiency and Accuracy: Eliminate the need to build models from scratch while ensuring precision and adaptability.
Key Features
- Customizable Forecast Parameters: Adjust essential inputs such as revenue growth, EBITDA %, and capital expenditures to fit your analysis.
- Instant DCF Valuation: Automatically calculates intrinsic value, NPV, and additional outputs with ease.
- High-Precision Accuracy: Leverages Yunnan Baiyao Group Co., Ltd’s real-world financial data for realistic valuation results.
- Effortless Scenario Analysis: Easily test various assumptions and compare results without hassle.
- Efficiency Booster: Streamline your workflow by removing the need to create intricate valuation models from the ground up.
How It Works
- Step 1: Download the Excel file.
- Step 2: Examine Yunnan Baiyao Group Co., Ltd's pre-filled financial data and projections.
- Step 3: Adjust key variables such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Evaluate the results and leverage them for your investment decisions.
Why Choose This Calculator for Yunnan Baiyao Group Co., Ltd (000538SZ)?
- Reliable Data: Accurate financial information for Yunnan Baiyao ensures trustworthy valuation outcomes.
- Tailor-Made: Modify essential factors such as growth rates, WACC, and tax rates to align with your forecasts.
- Efficiency Boost: Pre-existing calculations save you the trouble of starting from the ground up.
- Professional Quality: Tailored for investors, analysts, and consultants focused on Yunnan Baiyao.
- Easy to Use: Intuitive design and clear, step-by-step guidance make it accessible to all users.
Who Should Use This Product?
- Individual Investors: Gain insights for making informed decisions on buying or selling Yunnan Baiyao stock (000538SZ).
- Financial Analysts: Enhance your valuation processes with easy-to-implement financial models for Yunnan Baiyao (000538SZ).
- Consultants: Provide clients with accurate and timely valuation insights regarding Yunnan Baiyao (000538SZ).
- Business Owners: Learn how the valuation of a large company like Yunnan Baiyao (000538SZ) can influence your own business strategy.
- Finance Students: Explore valuation methodologies through practical applications using Yunnan Baiyao (000538SZ) data and scenarios.
What the Template Includes
- Pre-Filled DCF Model: Yunnan Baiyao Group's financial data preloaded for immediate analysis.
- WACC Calculator: Comprehensive calculations for the Weighted Average Cost of Capital.
- Financial Ratios: Assess Yunnan Baiyao's profitability, leverage, and operational efficiency.
- Editable Inputs: Modify assumptions such as growth rates, margins, and capital expenditures to suit your analysis.
- Financial Statements: Access annual and quarterly reports for in-depth examination.
- Interactive Dashboard: Effortlessly visualize essential valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.